Blis Technologies Ltd

BLIS Technologies Limited is a developer and manufacturer of innovative probiotic solutions.

Founded on the research of Professor John Tagg (University of Otago, New Zealand) the company was formed in 2000 to develop new bacterial species as probiotics for human health applications.

With specialist probiotic strains with specific health targets, BLIS offer partners a unique proposition. Their oral probiotic strains BLIS K12™ and BLIS M18™ are renowned for their efficacy and backed by 3o+ years of research, 20+ clinical studies and over 1 billion doses consumed worldwide.